These markers have been (1) detected at the site of disrupted plaques; (2) their systemic concentrations are elevated in patients with ACS; and (3) cutoff values distinguishing ACS from stable CAD have been reported [18–21] with the exception of IL-6. The gene discussed is IL6; the disease is coronary artery disorder.